Alpha 2.0

» Articles » PMID: 16220305

99mTc-interleukin-2 Scintigraphy for the in Vivo Imaging of Vulnerable Atherosclerotic Plaques

Overview

Overview

Journal Eur J Nucl Med Mol Imaging

Specialties Biophysics
Nuclear Medicine
Radiology

Date 2005 Oct 13

PMID 16220305

Citations 26

Authors

Authors

Alessio Annovazzi

Elena Bonanno

Marcello Arca

Calogero DAlessandria

Antonella Marcoccia

Luigi G Spagnoli

Francesco Violi

Francesco Scopinaro

Giorgio De Toma

Alberto Signore

Affiliations

Affiliations

Soon will be listed here.

Abstract

Purpose: Several histopathological studies have demonstrated that vulnerable plaques are enriched in inflammatory cells. The aims of this study were: (1a) to test the ability of 99mTc-labelled interleukin-2 (99mTc-IL2) to bind to IL2R-positive (IL2R+) cells in carotid plaques and (1b) to correlate the plaque uptake of 99mTc-IL2, measured in vivo, with the number of IL2R+ cells within the plaque, measured ex vivo by histology (transversal study, TS), and (2) to evaluate changes in 99mTc-IL2 uptake in plaques, before and after treatment with a statin or a hypocholesterolaemic diet (longitudinal study, LS).

Methods: Ultrasound scan was performed for plaque characterisation and localisation. Fourteen patients (16 plaques) eligible for endoarterectomy were recruited for the TS and underwent 99mTc-IL2 scintigraphy before surgery. Nine patients (13 plaques) were recruited for the LS; these patients received atorvastatin or a standard hypocholesterolaemic diet and 99mTc-IL2 scintigraphy was performed before and after 3 months of treatment.

Results: The degree of 99mTc-IL2 uptake was expressed as the plaque/background (T/B) ratio. In patients from TS, T/B ratios correlated with the percentage of IL2R+ cells at histology (r = 0.707; p = 0.002) and the number of IL2R+ cells at flow cytometry (r = 0.711; p = 0.006). No correlations were observed between ultrasound scores and either scintigraphic or histological findings. In patients from the LS, the mean 99mTc-IL2 uptake decreased in statin-treated patients (1.75+/-0.50 vs 2.16+/-0.44; p = 0.012), while it was unchanged in the patients on the hypocholesterolaemic diet (2.33+/-0.45 vs 2.34+/-0.5).

Conclusion: 99mTc-IL2 accumulates in vulnerable carotid plaques; this accumulation is correlated with the amount of IL2R+ cells and is influenced by lipid-lowering treatment with a statin.

Citing Articles

Emerging Nuclear Medicine Imaging of Atherosclerotic Plaque Formation.

Kondakov A, Berdalin A, Beregov M, Lelyuk V J Imaging. 2022; 8(10).

PMID: 36286355 PMC: 9605050. DOI: 10.3390/jimaging8100261.

Molecular Imaging of Vulnerable Coronary Plaque with Radiolabeled Somatostatin Receptors (SSTR).

Anzola L, Rivera J, Ramirez J, Signore A, Mut F J Clin Med. 2021; 10(23).

PMID: 34884218 PMC: 8658082. DOI: 10.3390/jcm10235515.

Cell-Based Tracers as Trojan Horses for Image-Guided Surgery.

Sier V, de Vries M, van der Vorst J, Vahrmeijer A, van Kooten C, Cruz L Int J Mol Sci. 2021; 22(2).

PMID: 33451116 PMC: 7828607. DOI: 10.3390/ijms22020755.

Imaging Technologies to Monitor the Immune System.

McCarthy C, White J, Viola N, Gibson H Front Immunol. 2020; 11:1067.

PMID: 32582173 PMC: 7280489. DOI: 10.3389/fimmu.2020.01067.

Current and novel radiopharmaceuticals for imaging cardiovascular inflammation.

Heo G, Sultan D, Liu Y Q J Nucl Med Mol Imaging. 2020; 64(1):4-20.

PMID: 32077667 PMC: 7985841. DOI: 10.23736/S1824-4785.20.03230-6.

References

1.

Qin G, Zhang Y, Cao W, An R, Gao Z, Li G . Molecular imaging of atherosclerotic plaques with technetium-99m-labelled antisense oligonucleotides. Eur J Nucl Med Mol Imaging. 2004; 32(1):6-14. DOI: 10.1007/s00259-004-1700-0. View

2.

Naghavi M, Libby P, Falk E, Casscells S, Litovsky S, Rumberger J . From vulnerable plaque to vulnerable patient: a call for new definitions and risk assessment strategies: Part I. Circulation. 2003; 108(14):1664-72. DOI: 10.1161/01.CIR.0000087480.94275.97. View

3.

Spagnoli L, Bonanno E, Mauriello A, Palmieri G, Partenzi A, Sangiorgi G . Multicentric inflammation in epicardial coronary arteries of patients dying of acute myocardial infarction. J Am Coll Cardiol. 2002; 40(9):1579-88. DOI: 10.1016/s0735-1097(02)02376-8. View

4.

Signore A, Chianelli M, Annovazzi A, Rossi M, Maiuri L, Greco M . Imaging active lymphocytic infiltration in coeliac disease with iodine-123-interleukin-2 and the response to diet. Eur J Nucl Med. 2000; 27(1):18-24. DOI: 10.1007/pl00006657. View

5.

Annovazzi A, Biancone L, Caviglia R, Chianelli M, Capriotti G, Mather S . 99mTc-interleukin-2 and (99m)Tc-HMPAO granulocyte scintigraphy in patients with inactive Crohn's disease. Eur J Nucl Med Mol Imaging. 2003; 30(3):374-82. DOI: 10.1007/s00259-002-1069-x. View

6.

Sukhova G, Williams J, Libby P . Statins reduce inflammation in atheroma of nonhuman primates independent of effects on serum cholesterol. Arterioscler Thromb Vasc Biol. 2002; 22(9):1452-8. DOI: 10.1161/01.atv.0000030360.72503.56. View

7.

Lederman R, Raylman R, Fisher S, Kison P, San H, Nabel E . Detection of atherosclerosis using a novel positron-sensitive probe and 18-fluorodeoxyglucose (FDG). Nucl Med Commun. 2001; 22(7):747-53. DOI: 10.1097/00006231-200107000-00004. View

8.

Yuan C, Tsuruda J, Beach K, Hayes C, Ferguson M, Alpers C . Techniques for high-resolution MR imaging of atherosclerotic plaque. J Magn Reson Imaging. 1994; 4(1):43-9. DOI: 10.1002/jmri.1880040111. View

9.

Leitha T, Staudenherz A, Gmeiner B, Hermann M, Huttinger M, Dudczak R . Technetium-99m labelled LDL as a tracer for quantitative LDL scintigraphy. II. In vivo validation, LDL receptor-dependent and unspecific hepatic uptake and scintigraphic results. Eur J Nucl Med. 1993; 20(8):674-9. DOI: 10.1007/BF00181757. View

10.

Rudd J, Warburton E, Fryer T, Jones H, Clark J, Antoun N . Imaging atherosclerotic plaque inflammation with [18F]-fluorodeoxyglucose positron emission tomography. Circulation. 2002; 105(23):2708-11. DOI: 10.1161/01.cir.0000020548.60110.76. View

11.

Prat L, Torres G, Carrio I, Roca M, Riambau V, Berna L . Polyclonal 111In-IgG, 125I-LDL and 125I-endothelin-1 accumulation in experimental arterial wall injury. Eur J Nucl Med. 1993; 20(12):1141-5. DOI: 10.1007/BF00171011. View

12.

Iuliano L, Signore A, Vallabajosula S, Colavita A, Camastra C, Ronga G . Preparation and biodistribution of 99m technetium labelled oxidized LDL in man. Atherosclerosis. 1996; 126(1):131-41. DOI: 10.1016/0021-9150(96)05888-1. View

13.

. Endarterectomy for moderate symptomatic carotid stenosis: interim results from the MRC European Carotid Surgery Trial. Lancet. 1996; 347(9015):1591-3. View

14.

Barnett H, Taylor D, Haynes R, Sackett D, Peerless S, Ferguson G . Beneficial effect of carotid endarterectomy in symptomatic patients with high-grade carotid stenosis. N Engl J Med. 1991; 325(7):445-53. DOI: 10.1056/NEJM199108153250701. View

15.

Chou E, Minutello R, Parikh M, Bergman G, Wong S, Hong M . Can we identify vulnerable patients at risk for ST-segment elevation myocardial infarction based on their clinical characteristics?. Coron Artery Dis. 2004; 15(8):467-9. DOI: 10.1097/00019501-200412000-00002. View

16.

Schumacher H, Kaiser E, Schnabel P, Sykora J, Eckstein H, Allenberg J . Immunophenotypic characterisation of carotid plaque: increased amount of inflammatory cells as an independent predictor for ischaemic symptoms. Eur J Vasc Endovasc Surg. 2001; 21(6):494-501. DOI: 10.1053/ejvs.2001.1362. View

17.

Tatsumi M, Cohade C, Nakamoto Y, Wahl R . Fluorodeoxyglucose uptake in the aortic wall at PET/CT: possible finding for active atherosclerosis. Radiology. 2003; 229(3):831-7. DOI: 10.1148/radiol.2293021168. View

18.

Knight L . Non-oncologic applications of radiolabeled peptides in nuclear medicine. Q J Nucl Med. 2004; 47(4):279-91. View

19.

Spagnoli L, Mauriello A, Sangiorgi G, Fratoni S, Bonanno E, Schwartz R . Extracranial thrombotically active carotid plaque as a risk factor for ischemic stroke. JAMA. 2004; 292(15):1845-52. DOI: 10.1001/jama.292.15.1845. View

20.

Muller J, Stone P, Turi Z, Rutherford J, Czeisler C, Parker C . Circadian variation in the frequency of onset of acute myocardial infarction. N Engl J Med. 1985; 313(21):1315-22. DOI: 10.1056/NEJM198511213132103. View